$INVE Cashflow Statement | Understand Stock

$INVE

$2.68 -$0.01 (0.37%) Close

$INVE Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net income (loss)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation and amortization
Provision for (recovery from) credit losses
Gain on forgiveness of Paycheck Protection Program note
Accretion of interest on contractual payment obligation
Gain on sale of discontinued operations, net of taxes
Amortization of operating lease right-of-use assets
Gain on investment
Write down of inventory
Loss on disposal of fixed assets
Amortization of debt issuance costs
Stock-based compensation
Stock-based compensation expense
Impairment of operating lease right-of-use assets
Loss on disposal of property and equipment
Changes in operating assets and liabilities:
Accounts receivable
Inventories
Prepaid expenses and other assets
Accounts payable
Contractual payment obligation liability
Deferred revenue
Accrued income taxes payable
Accrued expenses and other liabilities
Operating lease liabilities

Net cash used in operating activities
Cash flows from investing activities:
Capital expenditures
Proceeds from sale of discontinued operations, net of cash sold
Proceeds from investment
Net cash provided by (used in) investing activities
Cash flows from financing activities:
Borrowings under revolving loan facility, net of issuance costs
Repayments under revolving loan facility
Repayments of April 21 Funds promissory notes
Proceeds from the sale of common stock, net of issuance costs
Taxes paid related to net share settlement of restricted stock units
Repurchases of common stock
Proceeds from exercise of warrants
Proceeds from exercise of stock options
Net cash used in financing activities

Effect of exchange rates on cash, cash equivalents, and restricted cash
Net increase (decrease) in cash, cash equivalents, and restricted cash
Cash, cash equivalents, and restricted cash, Beginning of period
Cash, cash equivalents, and restricted cash, End of period
Supplemental Disclosures of Cash Flow Information:
Interest paid
Income taxes payments (refunds), net
Non-cash investing and financing activities:
Dividends earned on Series B preferred stock
Operating lease right-of-use assets obtained in exchange for operating lease liabilities
Reclassification of debt issuance costs to prepaid expenses and other current assets

Comments